May 9 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA
* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA
* Clinical study was approved by Australian government department of health therapeutic goods administration Source text for Eikon: ID:nGNXNUTTRa Further company coverage: ABEO.O